CIK 0001082554 · Large accelerated filer
UNITED THERAPEUTICS Corp
Sign in to watch- Ticker
- UTHR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 521984749
- Phone
- 3016089292
- Business address
- 1000 SPRING ST, SILVER SPRING, MD, 20910
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $342,072,960
- in 74 filings, $341.3M under 10b5-1 plans
Net −$342,072,960. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-05-29 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −841 | $558.81 | $470K | 40,833 |
| 2026-05-29 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −320 | $559.41 | $179K | 40,513 |
| 2026-05-29 | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise · Stock Option 10b5-1 | −9,500 | 135,910 | ||
| 2026-05-28 | EDGEMOND JAMES CFO AND TREASURER | Option exercise 10b5-1 | +10,000 | $117.76 | $1.2M | 28,876 |
| 2026-05-28 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −320 | $561.48 | $180K | 28,556 |
| 2026-05-28 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −1,961 | $562.77 | $1.1M | 26,595 |
| 2026-05-28 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −1,675 | $563.87 | $944K | 24,920 |
| 2026-05-28 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −1,208 | $564.82 | $682K | 23,712 |
| 2026-05-28 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −893 | $566.00 | $505K | 22,819 |
| 2026-05-28 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −934 | $566.87 | $529K | 21,885 |
| 2026-05-28 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −1,605 | $567.91 | $912K | 20,280 |
| 2026-05-28 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −844 | $568.90 | $480K | 19,436 |
| 2026-05-28 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −332 | $570.50 | $189K | 19,104 |
| 2026-05-28 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −228 | $571.48 | $130K | 18,876 |
| 2026-05-28 | EDGEMOND JAMES CFO AND TREASURER | Option exercise · Stock Option 10b5-1 | −10,000 | 50,000 | ||
| 2026-05-28 | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise 10b5-1 | +9,500 | $146.03 | $1.4M | 50,013 |
| 2026-05-28 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −295 | $561.53 | $166K | 49,718 |
| 2026-05-28 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,520 | $562.59 | $855K | 48,198 |
| 2026-05-28 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,638 | $563.68 | $923K | 46,560 |
| 2026-05-28 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,369 | $564.59 | $773K | 45,191 |
Page 93 of 120 · 2,391 trades